CN116196361A - 一种中医药保健品及其制备方法 - Google Patents
一种中医药保健品及其制备方法 Download PDFInfo
- Publication number
- CN116196361A CN116196361A CN202310439691.4A CN202310439691A CN116196361A CN 116196361 A CN116196361 A CN 116196361A CN 202310439691 A CN202310439691 A CN 202310439691A CN 116196361 A CN116196361 A CN 116196361A
- Authority
- CN
- China
- Prior art keywords
- liver
- health product
- traditional chinese
- chinese medicine
- medicinal materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000036541 health Effects 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 210000004185 liver Anatomy 0.000 claims abstract description 44
- 239000003814 drug Substances 0.000 claims abstract description 25
- 241000244938 Penthorum chinense Species 0.000 claims abstract description 17
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 15
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 15
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 14
- 241000222355 Trametes versicolor Species 0.000 claims abstract description 14
- 241000132012 Atractylodes Species 0.000 claims abstract description 13
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims abstract description 13
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims abstract description 13
- 244000110343 Elephantopus scaber Species 0.000 claims abstract description 13
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 13
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 13
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 13
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 13
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 13
- 235000011477 liquorice Nutrition 0.000 claims abstract description 13
- 238000004140 cleaning Methods 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 238000001035 drying Methods 0.000 claims abstract description 7
- 238000010298 pulverizing process Methods 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims description 33
- 241000628997 Flos Species 0.000 claims description 12
- 244000185386 Thladiantha grosvenorii Species 0.000 claims description 10
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims description 10
- 241001317575 Elephantopus Species 0.000 claims description 4
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 235000009815 Momordica Nutrition 0.000 abstract 1
- 241000218984 Momordica Species 0.000 abstract 1
- 239000002445 liver protective agent Substances 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 17
- 244000025254 Cannabis sativa Species 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 208000019425 cirrhosis of liver Diseases 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- SQWFNVMZGIOFHT-UHFFFAOYSA-N 2,2-bis(4-methoxyphenyl)-5,6-dimethylbenzo[h]chromene Chemical compound C1=CC(OC)=CC=C1C1(C=2C=CC(OC)=CC=2)C=CC(C(C)=C(C)C=2C3=CC=CC=2)=C3O1 SQWFNVMZGIOFHT-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 241001189830 Fissistigma Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000594394 Hedyotis Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- FDQAOULAVFHKBX-UHFFFAOYSA-N Isosilybin A Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC(=CC=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 FDQAOULAVFHKBX-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- VLGROHBNWZUINI-UHFFFAOYSA-N Silybin Natural products COc1cc(ccc1O)C2OC3C=C(C=CC3OC2CO)C4Oc5cc(O)cc(O)c5C(=O)C4O VLGROHBNWZUINI-UHFFFAOYSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002075 anti-alcohol Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000000514 hepatopancreas Anatomy 0.000 description 1
- 230000008076 immune mechanism Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 229930186179 lupulin Natural products 0.000 description 1
- PEFNSGRTCBGNAN-QNDFHXLGSA-N luteolin 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-QNDFHXLGSA-N 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 229940043175 silybin Drugs 0.000 description 1
- 235000014899 silybin Nutrition 0.000 description 1
- 235000021259 spicy food Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了提供一种中医药保健品及其制备方法,中医药保健品由下列原料按重量份配比赶黄草10‑20克、软肝草30‑50克、地胆头40‑60克、野菊花40‑60克、金银花40‑60克、罗汉果10‑30克、云芝10‑20克、枸杞20‑30克、白术5‑20克以及甘草1‑20克;制备方法,包括:采摘,清理,晒干,粉碎,配比,包裹。有益效果为:具有保护肝脏的功能,不会增加肝脏的负担;制作方法简单,不需要太高的专业技术,易操作,易实现,能够被广泛推广。
Description
技术领域
本发明涉及医药保健领域,特别涉及一种中医药保健品及其制备方法。
背景技术
肝脏是身体内以代谢功能为主的一个器官,并在身体里面起着去氧化、储存肝糖、分泌性蛋白质的合成等作用。肝脏也制造消化系统中之胆汁。肝脏是人体内脏里最大的器官,位于人体中的腹部位置,在右侧横隔膜之下,位于胆囊之前端且于右边肾脏的前方,胃的上方。肝脏是人体消化系统中最大的消化腺,成人肝脏平均重达1.5公斤(约在1-2.5公斤之间;另一说1-1.6公斤),为一红棕色的V字形器官。肝脏是尿素合成的主要器官,又是新陈代谢的重要器官。
通过上述可知,保护肝脏非常重要,现有护肝脏的产品有护肝片,肌苷片,肝泰乐,水飞蓟宾胶囊等,但是这些产品都会增加肝脏的负担,因此现在亟需一种不会增加肝脏负担的保健品。
发明内容
为解决上述问题,尤其是针对现有技术所存在的不足,本发明提供了一种中医药保健品及其制备方法能够解决上述问题。
为实现上述目的,本发明采用以下技术手段:
一种中医药保健品,是由下列原料按重量份配比制成的药剂:赶黄草10-20克、软肝草30-50克、地胆头40-60克、野菊花40-60克、金银花40-60克、罗汉果10-30克、云芝10-20克、枸杞20-30克、白术5-20克以及甘草1-20克。
本发明进一步的方案为,所述赶黄草,软肝草,地胆头之间的比例为1:3:4。
本发明进一步的方案为,是由下列原料按重量份配比制成的药剂:赶黄草10克、软肝草30克、地胆头40克、野菊花40克、金银花40克、罗汉果10克、云芝10克、枸杞20克、白术5克以及甘草1克。
本发明进一步的方案为,是由下列原料按重量份配比制成的药剂:赶黄草11克、软肝草33克、地胆头44克、野菊花50克、金银花50克、罗汉果20克、云芝15克、枸杞25克、白术10克以及甘草10克。
本发明进一步的方案为,是由下列原料按重量份配比制成的药剂:赶黄草15克、软肝草45克、地胆头60克、野菊花60克、金银花60克、罗汉果30克、云芝20克、枸杞30克、白术20克以及甘草20克。
一种中医药保健品的制备方法,包括以下步骤:
第一步:将需要用到的赶黄草、软肝草、地胆头、野菊花、金银花、罗汉果、云芝、枸杞、白术以及甘草进行采摘;
第二步:采摘完成之后对药材进行分类清理操作,清理混合在里面的杂物;
第三步:将清理完成的药材进行分类晒干;
第四步:将不同的药材分类放入粉碎机内进行粉碎操作;
第五步:粉碎后的药材按照对应的重量份配比;
第六步:重量份配比好的药材通过纱布包裹即可。
赶黄草,其具有清热解毒、退黄化湿、活血散瘀、利水消肿之功效,现代研究表明,赶黄草含有没食子酸和槲皮素,有抗肝病毒和保护肝的有效成分,能恢复肝功能,减低饮酒和药物对肝脏的损害,地胆头,多年生直立草本,全草都可以入药,是一种常见药草。具有清热解毒、消肿止痛的功效。
清热解毒地胆头味苦,药性偏寒,具有清热解毒的功效。很多人喜欢吃辛辣的食物,会导致体内火气不断累积变成火毒,引发各种并发症,此时服用地胆头,可以清热解毒和降火,在食用地胆头的同时,也要改变饮食习性,保持清淡的饮食习惯,使身体更快恢复。消肿止痛地胆头中含有某些成分,有活血化瘀以及消肿止痛的作用,能促进血液流动,使肿痛处更快消肿,一定程度的减轻患处的疼痛感,能治疗跌打损伤。地胆头主要含有萜类、黄酮类、甾体类等化合物,还含有蛇麻脂醇、豆甾醇及卅烷醇、卅二烷醇、氯化钾、去氧地胆草素、异去氧地胆草素,其鲜花中可分离出木犀草素,葡萄糖甙等生物活性物质,这些物质使得地胆头对多种细菌具有抑制作用。
软肝草仅生长于南方丘陵向阳之侧,四季青翠,有独特烟草型芳香,数量稀少而珍贵。软肝草是一种被两广地区叫做爬地莲的植物,是当地人民用来做药膳的主要材料之一。具有清热解毒、护肝明目、消炎和解酒等功效。清热解毒软肝草具有清热解毒的功效,可以有效缓解上火引起的口燥咽干、便秘尿黄、红肿热痛、舌红苔黄等症状。护肝明目软肝草还有软肝、护肝以及增强肝脏自我解毒能力的功效,如果合理食用软肝草,可以恢复肝脏内的细胞活力,因而软肝草对肝脏病人来说是一味重要的药材,软肝草的作用可重点体现在肝硬化、肝腹水等病的治疗上。消炎软肝草具有消炎的功效,能消灭人体内多种敏感菌和致病菌,增强人体的抗病毒能力,提高身体素质,而且能让人体内的炎症尽快消退。解酒软肝草具有解酒的功效,饮酒过多会导致肝硬化,靠药物治疗会对身体产生比较大的损伤,此时可以应用软肝草进行辅助治疗。可以软化肝脏纤维化,使得肝脏变软。软肝草内含共同生物活性生命因子,可在人体内组成糖蛋白,全面调理机体免疫机制,影响机体发生内源性干扰素和肝细胞再生素,减轻肝脏病理危害,修正肝细胞损害。
野菊花具有清热解毒、清肝明目、清风散热、消炎。野菊花可用于治疗咽喉肿痛、头痛、眩晕;金银花的主要作用是清热解毒、疏散风热,可以应用于外感风热症或者是温病的初期;罗汉果具有清肺利咽,化痰止咳,润肠通便。云芝有健脾利湿,清热解毒的功效;枸杞子中含有多种氨基酸,并含有甜菜碱、玉蜀黍黄素、酸浆果红素等特殊营养成分,具有调节免疫、抗衰老、调节血脂的功效,白术性温,味甘、微辛带苦,入脾经和胃经,具有利尿消肿、固表止汗、燥湿健脾、抗氧化等功效;甘草为豆科植物甘草、光果甘草或胀果甘草的根及根茎。性平,味甘,归心经、胃经、脾经、肺经,具有抗酸、镇咳化痰、抗炎、抗过敏的功效。
本发明的有益效果为:
1、本发明由中药搭配而成,对人体没有伤害,具有保护肝脏的功能,同时,不会增加肝脏的负担。
2、本发明由赶黄草、软肝草、地胆头、野菊花、金银花、罗汉果、云芝、枸杞、白术以及甘草搭配而成,不仅可以达到补气养血,生津止渴,降低血糖和胆固醇,软化血管,润肺除痰,疏肝理气,清热解毒,护肝保肝等功效,而且还添加了护胃益肾的草本精华,对人体具有较好的保健效果。
3、本发的制作方法简单,不需要太高的专业技术,易操作,易实现,能够被广泛推广。
具体实施方式
下面用具体实施例说明本发明,并不是对本发明的限制。
实施例1
一种中医药保健品的制备方法,包括以下步骤:
第一步:将需要用到的赶黄草、软肝草、地胆头、野菊花、金银花、罗汉果、云芝、枸杞、白术以及甘草进行采摘;
第二步:采摘完成之后对药材进行分类清理操作,清理混合在里面的杂物;
第三步:将清理完成的药材进行分类晒干;
第四步:将不同的药材分类放入粉碎机内进行粉碎操作;
第五步:粉碎后的药材按照赶黄草10克、软肝草30克、地胆头40克、野菊花40克、金银花40克、罗汉果10克、云芝10克、枸杞20克、白术5克、甘草1克的规定进行配比;
第六步:重量份配比好的药材通过纱布包裹即可。
实施例2
一种中医药保健品的制备方法,包括以下步骤:
第一步:将需要用到的赶黄草、软肝草、地胆头、野菊花、金银花、罗汉果、云芝、枸杞、白术以及甘草进行采摘;
第二步:采摘完成之后对药材进行分类清理操作,清理混合在里面的杂物;
第三步:将清理完成的药材进行分类晒干;
第四步:将不同的药材分类放入粉碎机内进行粉碎操作;
第五步:粉碎后的药材按照赶黄草11克、软肝草33克、地胆头44克、野菊花50克、金银花50克、罗汉果20克、云芝15克、枸杞25克、白术10克、甘草10克的规定进行配比;
第六步:重量份配比好的药材通过纱布包裹即可。
实施例3
一种中医药保健品的制备方法,包括以下步骤:
第一步:将需要用到的赶黄草、软肝草、地胆头、野菊花、金银花、罗汉果、云芝、枸杞、白术以及甘草进行采摘;
第二步:采摘完成之后对药材进行分类清理操作,清理混合在里面的杂物;
第三步:将清理完成的药材进行分类晒干;
第四步:将不同的药材分类放入粉碎机内进行粉碎操作;
第五步:粉碎后的药材按照赶黄草15克、软肝草45克、地胆头60克、野菊花60克、金银花60克、罗汉果30克、云芝20克、枸杞30克、白术20克、甘草20克的规定进行配比;
第六步:重量份配比好的药材通过纱布包裹即可。
以上所述,仅为本发明较佳的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,根据本发明的技术方案及其发明构思加以等同替换或改变,都应涵盖在本发明的保护范围之内。
Claims (6)
1.一种中医药保健品,其特征在于,是由下列原料按重量份配比制成的药剂:赶黄草10-20克、软肝草30-50克、地胆头40-60克、野菊花40-60克、金银花40-60克、罗汉果10-30克、云芝10-20克、枸杞20-30克、白术5-20克以及甘草1-20克。
2.根据权利要求1所述的一种中医药保健品,其特征在于,所述赶黄草,软肝草,地胆头之间的比例为1:3:4。
3.根据权利要求2所述的一种中医药保健品,其特征在于,是由下列原料按重量份配比制成的药剂:赶黄草10克、软肝草30克、地胆头40克、野菊花40克、金银花40克、罗汉果10克、云芝10克、枸杞20克、白术5克以及甘草1克。
4.根据权利要求2所述的一种中医药保健品,其特征在于,是由下列原料按重量份配比制成的药剂:赶黄草11克、软肝草33克、地胆头44克、野菊花50克、金银花50克、罗汉果20克、云芝15克、枸杞25克、白术10克以及甘草10克。
5.根据权利要求2所述的一种中医药保健品,其特征在于,是由下列原料按重量份配比制成的药剂:赶黄草15克、软肝草45克、地胆头60克、野菊花60克、金银花60克、罗汉果30克、云芝20克、枸杞30克、白术20克以及甘草20克。
6.一种权利要求1所述的中医药保健品的制备方法,其特征在于,包括以下步骤:
第一步:将需要用到的赶黄草、软肝草、地胆头、野菊花、金银花、罗汉果、云芝、枸杞、白术以及甘草进行采摘;
第二步:采摘完成之后对药材进行分类清理操作,清理混合在里面的杂物;
第三步:将清理完成的药材进行分类晒干;
第四步:将不同的药材分类放入粉碎机内进行粉碎操作;
第五步:粉碎后的药材按照对应的重量份配比;
第六步:重量份配比好的药材通过纱布包裹即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310439691.4A CN116196361A (zh) | 2023-04-23 | 2023-04-23 | 一种中医药保健品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310439691.4A CN116196361A (zh) | 2023-04-23 | 2023-04-23 | 一种中医药保健品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116196361A true CN116196361A (zh) | 2023-06-02 |
Family
ID=86513187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310439691.4A Withdrawn CN116196361A (zh) | 2023-04-23 | 2023-04-23 | 一种中医药保健品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116196361A (zh) |
-
2023
- 2023-04-23 CN CN202310439691.4A patent/CN116196361A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018021886A1 (ko) | 혼합 생약제 추출물을 유효성분으로 포함하는 숙취해소, 피로회복 및 면역력 증강용 식품 조성물 | |
KR20020022342A (ko) | 스트레스 예방 및 치료를 위한 항스트레스제 조성물 | |
KR101930277B1 (ko) | 숙취 예방 및 개선용 조성물 | |
CN106359720A (zh) | 一种清咽利喉和润肺清火的保健茶及其制备方法 | |
KR20020037218A (ko) | 한약재 증류수를 이용한 다이어트 음료수 제조방법 | |
CN102715509B (zh) | 一种排毒养颜保健品 | |
KR20160000695A (ko) | Dha 함유 기억력 강화 및 피로회복 증진용 한약재 조성물 수능환 및 그 제조방법 | |
KR101224196B1 (ko) | 비타민나무 추출물과 생약제가 함유된 오메가 - 3 제조방법 | |
CN100577193C (zh) | 一种醒酒保健品 | |
CN103859373A (zh) | 一种有助于经期养生的养生保健食品配方及其制备方法 | |
TW202330006A (zh) | 氣虛及/或血虛相關症狀之預防、改善或緩和用之組合物 | |
CN107823293A (zh) | 治疗口腔溃疡的瑶医外用散剂及其制备方法 | |
KR101783549B1 (ko) | Dha 함유 피로회복 증진 보조식품용 조성물 수능단(수능원) 및 그 제조방법 | |
CN114651968A (zh) | 一种宿醉解酒组合物配方及其制备方法 | |
CN108419869A (zh) | 一种清热排毒下火的组合物、饮料及其制备方法 | |
CN116196361A (zh) | 一种中医药保健品及其制备方法 | |
CN103181431A (zh) | 一种养肝保健茶及其制备方法 | |
CN111084878A (zh) | 一种用于肺及呼吸系统疾病的生物医药、医用全营养食品及制备方法 | |
CN104623615A (zh) | 一种治疗哮喘的药物 | |
KR20200061446A (ko) | 함초를 이용한 식품 조성물 및 그 제조방법 | |
CN107854592A (zh) | 一种可快速消除疼痛感的口腔溃疡贴膜的制备方法 | |
CN114601165B (zh) | 一种减肥、祛湿的组合物及其制备工艺、制剂与应用 | |
KR102217732B1 (ko) | 조기성숙 가성 유방 발달의 예방 또는 개선용 조성물 | |
CN105412813A (zh) | 一种滋阴补肾祛斑美容口服液 | |
CN106039075A (zh) | 一种治疗肺胃蕴热型慢性咽炎的中药组合物及方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20230602 |
|
WW01 | Invention patent application withdrawn after publication |